Aclidinium bromide 400 mcg/ACTUAT / formoterol fumarate 12 mcg/ACTUAT Dry Powder Inhaler, 30 Actuations
RxNorm 2205103

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2205103 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: aclidinium bromide 400 mcg/ACTUAT / formoterol fumarate 12 mcg/ACTUAT Dry Powder Inhaler, 30 Actuations.

The following semantic concepts and normalized strings are associated with this clinical entity:

SCD
30 ACTUAT aclidinium bromide 0.4 mg/ACTUAT / formoterol fumarate 0.012 mg/ACTUAT Dry Powder Inhaler
Primary clinical definition
AUI:11455808
View
PSN
Aclidinium bromide 400 mcg/ACTUAT / formoterol fumarate 12 mcg/ACTUAT Dry Powder Inhaler, 30 Actuations
AUI:11456791
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SCDPrescribable

Semantic Clinical Drug (SCD):
30 ACTUAT aclidinium bromide 0.4 mg/ACTUAT / formoterol fumarate 0.012 mg/ACTUAT Dry Powder Inhaler
(Atom ID: 11455808)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
30 ACTUAT aclidinium bromide 0.4 MG/ACTUAT / formoterol fumarate 0.012 MG/ACTUAT Dry Powder Inhaler
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2205103
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
11455808
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SCD
Semantic Clinical Drug (Ingredient + Strength + Dose Form)
Source Code
2205103
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN ACTIVATED
01/30/2024
Date the RxNorm atom was reactivated
RXN AI
{1303099} 1303097
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{2205090} 236216
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{1303099} 1303098
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{2205090} 25255
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AVAILABLE STRENGTH
0.4 MG/ACTUAT (expressed as aclidinium bromide) / 0.012 MG/ACTUAT (expressed as formoterol fumarate)
Available drug strengths listed in the order of ingredients from the drug
RXN BOSS FROM
{1303099} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{2205090} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN HUMAN DRUG
US
Drug available for use in Humans
RXN OBSOLETED
08/29/2022
Date the RxNorm atom became obsolete
RXN QUANTITY
30 ACTUAT
Normal Form quantity factor
RXTERM FORM
DPI
The RxTerm dose form name for this drug
PSNPrescribable

Prescribable Name (PSN):
Aclidinium bromide 400 mcg/ACTUAT / formoterol fumarate 12 mcg/ACTUAT Dry Powder Inhaler, 30 Actuations
(Atom ID: 11456791)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
aclidinium bromide 400 MCG/ACTUAT / formoterol fumarate 12 MCG/ACTUAT Dry Powder Inhaler, 30 Actuations
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2205103
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
11456791
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
2205103
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

Aclidinium Oral Inhalation


Aclidinium is used as a long term treatment to prevent wheezing, shortness of breath, coughing, and chest tightness in patients with chronic obstructive pulmonary disease (COPD, a group of diseases that affect the lungs and airways) such as chronic bronchitis (swelling of the air passages that lead to the lungs) and emphysema (damage to air sacs in the lungs). Aclidinium is in a class of medications called bronchodilators. It works by relaxing and opening the air passages to the lungs to make breathing easier.
[Learn More]


Formoterol Oral Inhalation


Formoterol oral inhalation is used to control wheezing, shortness of breath, and chest tightness caused by chronic obstructive pulmonary disease (COPD; a group of lung diseases that includes chronic bronchitis and emphysema). Formoterol is in a class of medications called long-acting beta agonists (LABAs). It works by relaxing and opening air passages in the lungs, making it easier to breathe.
[Learn More]


* Please review the disclaimer below.